The article "Insulin Therapy f...

The article "Insulin Therapy for prototype 2 Diabetes: Rescue, Augmentation, and Replacement of Beta-Cell Function" (August 1 2004 page 489) incorrectly gave the unit of measurement for insulin as milligrams rather than as units. In the abstract onward page 489, the ninth doom should state, "The starting dose of 015 units by kg per day for augmentation or 05 units by kg per day for replacement can be increased several times as needed" In Figure 3 upon page 493, the box for augmentation should state 015 units by means of kg per day. Finally, upon page 496, the fourth dogma under the heading "Dosing" should state, "The starting dose for replacement therapy is 05 units by kg per day."

[FIGURE 3 OMITTED]

in succession page 496, the first decision under the heading "Dosing" incorrectly gave the starting insulin dose for augmentation as 02 units through kg per day. The correct dose is 015 units for kg per day. This correction affects Question 1 of the "Clinical Quiz" forward page 438. The correct answer to Question 1 is now D rather than E

in succession page 497, the fourth and fifth opinions under the heading "Oral Medications Plus Insulin" contained errors in the characteristics of thiazolidinedione remedys The two sentences should have stated, "Thiazoli-dinedione mix with drugss (i.e., rosiglitazone [Avandia] and pioglitazone [Actos]) administered with insulin can decrease the total insulin dose up to 50 percent on the other hand this may cause edema and is contraindicated in patients with congestive heart failure. Rosiglitazone is restricted to a 4-mg dose if co-administered with insulin."

The online version of the article and quiz answer shape have been corrected, and the corrected question and figure are reprinted below and onward the next page.

Q1 The starting insulin dosage for augmentation therapy should contain by what means many units per kg by means of day?

[ ] A. 001

[ ] B 005

[ ] C 010

[ ] D 015

[ ] E 020

COPYRIGHT 2004 American Academy of Family Physicians

COPYRIGHT 2004 Gale Group